Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 714964, 11 pages
http://dx.doi.org/10.1155/2015/714964
Research Article

Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family

1Renal Research Laboratory, Research and Development, MBRF and Kansas City VA Medical Center, Kansas City, MO 64128, USA
2Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
3Section of Nephrology, Children’s Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO 64108, USA
4Section of Cardiac Surgery, Children’s Mercy Hospital and University of Missouri at Kansas City, Kansas City, MO 64108, USA
5Department of Pharmacology, University of Montreal, Montreal, QC, Canada H3T 1J4

Received 1 March 2015; Accepted 13 May 2015

Academic Editor: Clelia M. Riera

Copyright © 2015 Virginia J. Savin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Shi, W. Wang, P. A. Yourey et al., “Computational EST database analysis identifies a novel member of the neuropoietic cytokine family,” Biochemical and Biophysical Research Communications, vol. 262, no. 1, pp. 132–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Senaldi, B. C. Varnum, C. S. Ulla Sarmiento et al., “Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11458–11463, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Vlotides, K. Zitzmann, G. K. Stalla, and C. J. Auernhammer, “Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3)/cardiotrophin-like cytokine (CLC)—a novel gp130 cytokine with pleiotropic functions,” Cytokine & Growth Factor Reviews, vol. 15, no. 5, pp. 325–336, 2004. View at Publisher · View at Google Scholar
  4. G. C. A. Elson, E. Lelièvre, C. Guillet et al., “CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex,” Nature Neuroscience, vol. 3, no. 9, pp. 867–872, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Plun-Favreau, G. Elson, M. Chabbert et al., “The ciliary neurotrophic factor receptor α component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine,” The EMBO Journal, vol. 20, no. 7, pp. 1692–1703, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. N. G. Forger, D. Prevette, O. DeLapeyrière et al., “Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo,” The Journal of Neuroscience, vol. 23, no. 26, pp. 8854–8858, 2003. View at Google Scholar · View at Scopus
  7. D. J. Kass, G. Yu, K. S. Loh et al., “Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury,” The American Journal of Pathology, vol. 180, no. 5, pp. 1963–1978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. V. J. Savin, R. Sharma, M. Sharma et al., “Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis,” The New England Journal of Medicine, vol. 334, no. 14, pp. 878–883, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sharma, M. Sharma, X. Ge, E. T. Mccarthy, and V. J. Savin, “Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP,” Transplantation, vol. 62, no. 12, pp. 1916–1920, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. M. L. Artero, R. Sharma, V. J. Savin, and F. Vincenti, “Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis,” American Journal of Kidney Diseases, vol. 23, no. 4, pp. 574–581, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Hariharan, V. R. Peddi, V. J. Savin et al., “Recurrent and De Novo renal diseases after renal transplantation: a report from the renal allograft disease registry,” American Journal of Kidney Diseases, vol. 31, no. 6, pp. 928–931, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Sharma, M. Sharma, E. T. McCarthy, X.-L. Ge, and V. J. Savin, “Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro,” Kidney International, vol. 58, no. 5, pp. 1973–1979, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Sharma, R. Sharma, E. T. Mccarthy, and V. J. Savin, “‘The FSGS factor’: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma,” Journal of the American Society of Nephrology, vol. 10, no. 3, pp. 552–561, 1999. View at Google Scholar · View at Scopus
  14. M. Sharma, R. Sharma, S. R. Reddy, E. T. McCarthy, and V. J. Savin, “Proteinuria after injection of human focal segmental glomerulosclerosis factor,” Transplantation, vol. 73, no. 3, pp. 366–372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. E. T. McCarthy, M. Sharma, and V. J. Savin, “Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 11, pp. 2115–2121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Boute, O. Gribouval, S. Roselli et al., “NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome,” Nature Genetics, vol. 24, no. 4, pp. 349–354, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Kaplan, S. H. Kim, K. N. North et al., “Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis,” Nature Genetics, vol. 24, no. 3, pp. 251–256, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Winn, P. J. Conlon, K. L. Lynn et al., “A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis,” Science, vol. 308, no. 5729, pp. 1801–1804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. J. Brown, J. S. Schlöndorff, D. J. Becker et al., “Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis,” Nature Genetics, vol. 42, no. 1, pp. 72–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Boyer, G. Benoit, O. Gribouval et al., “Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis,” Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 239–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Hoyer, R. L. Vernier, J. S. Najarian, L. Raij, R. L. Simmons, and A. F. Michael, “Recurrence of idiopathic nephrotic syndrome after renal transplantation,” The Lancet, vol. 2, no. 7773, pp. 343–348, 1972. View at Google Scholar · View at Scopus
  22. C. Kennedy, A. Obilana, F. O'Brien et al., “Glomerular disease recurrence in second and subsequent kidney transplants,” Clinical Nephrology, vol. 79, no. 1, pp. 31–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Trachtman, S. S. Sran, and H. Trachtman, “Recurrent focal segmental glomerulosclerosis after kidney transplantation,” Pediatric Nephrology, 2015. View at Publisher · View at Google Scholar
  24. R. J. M. Coward, R. R. Foster, D. Patton et al., “Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 629–637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Wei, S. El Hindi, J. Li et al., “Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis,” Nature Medicine, vol. 17, no. 8, pp. 952–960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Musante, G. Candiano, M. Bruschi et al., “Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli,” Proteomics, vol. 2, no. 2, pp. 197–205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Tormo, Y. Meliani, L. A. Beaupré et al., “The composite cytokine p28/cytokine-like factor 1 sustains B cell proliferation and promotes plasma cell differentiation,” The Journal of Immunology, vol. 191, no. 4, pp. 1657–1665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. V. J. Savin, R. Sharma, H. B. Lovell, and D. J. Welling, “Measurement of albumin reflection coefficient with isolated rat glomeruli,” Journal of the American Society of Nephrology, vol. 3, no. 6, pp. 1260–1269, 1992. View at Google Scholar · View at Scopus
  29. P. Mundel and W. Kriz, “Cell culture of podocytes,” Experimental Nephrology, vol. 4, no. 5, pp. 263–266, 1996. View at Google Scholar · View at Scopus
  30. F. Rousseau, J.-F. Gauchat, J. G. McLeod et al., “Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 26, pp. 10068–10073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Cognet, F. Guilhot, M. Gabriac et al., “Cardiotrophin-like cytokine labelling using Bir a biotin ligase: a sensitive tool to study receptor expression by immune and non-immune cells,” Journal of Immunological Methods, vol. 301, no. 1-2, pp. 53–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. J. Tormo, M.-C. Letellier, R. Lissilaa et al., “The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities,” Cytokine, vol. 60, no. 3, pp. 653–660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Zou, B. Bolon, J. K. Pretorius et al., “Neonatal death in mice lacking cardiotrophin-like cytokine is associated with multifocal neuronal hypoplasia,” Veterinary Pathology, vol. 46, no. 3, pp. 514–519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. Auernhammer, N. B. Isele, F. B. Kopp et al., “Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3,” Endocrinology, vol. 144, no. 4, pp. 1202–1210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Nogueira-Silva, P. Piairo, E. Carvalho-Dias, C. Veiga, R. S. Moura, and J. Correia-Pinto, “The role of glycoprotein 130 family of cytokines in fetal rat lung development,” PLoS ONE, vol. 8, no. 6, Article ID e67607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. K. M. Schmidt-Ott, J. Yang, X. Chen et al., “Novel regulators of kidney development from the tips of the ureteric bud,” Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 1993–2002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Aljabari, E. Howard, T. Bell, and T. L. Vasylyeva, “Cold induced sweating syndrome with urinary system anomaly association,” Case Reports in Pediatrics, vol. 2013, Article ID 173890, 4 pages, 2013. View at Publisher · View at Google Scholar
  38. M. Sharma, J. Zhou, J. Gauchat et al., “Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier,” Translational Research, 2015. View at Publisher · View at Google Scholar
  39. G. Senaldi, M. Stolina, J. Guo et al., “Regulatory effects of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function,” Journal of Immunology, vol. 168, no. 11, pp. 5690–5698, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. J. E. Darnell Jr., “STATs and gene regulation,” Science, vol. 277, no. 5332, pp. 1630–1635, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. B. B. Aggarwal, A. B. Kunnumakkara, K. B. Harikumar et al., “Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?” Annals of the New York Academy of Sciences, vol. 1171, pp. 59–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. He and M. Karin, “NF-κB and STAT3- key players in liver inflammation and cancer,” Cell Research, vol. 21, no. 1, pp. 159–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Decker and P. Kovarik, “Serine phosphorylation of STATs,” Oncogene, vol. 19, no. 21, pp. 2628–2637, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Pietrocola, V. Izzo, M. Niso-Santano et al., “Regulation of autophagy by stress-responsive transcription factors,” Seminars in Cancer Biology, vol. 23, no. 5, pp. 310–322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Gong, A. R. Muñoz, D. Chan, R. Ghosh, and A. P. Kumar, “STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth,” Oncotarget, vol. 5, no. 9, pp. 2529–2541, 2014. View at Google Scholar · View at Scopus
  46. R. Liu, Y. Zhong, X. Li et al., “Role of transcription factor acetylation in diabetic kidney disease,” Diabetes, vol. 63, no. 7, pp. 2440–2453, 2014. View at Google Scholar
  47. A. Kalli and S. Hess, “Effect of mass spectrometric parameters on peptide and protein identification rates for shotgun proteomic experiments on an LTQ-orbitrap mass analyzer,” Proteomics, vol. 12, no. 1, pp. 21–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Delville, T. K. Sigdel, C. Wei et al., “A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation,” Science Translational Medicine, vol. 6, no. 256, Article ID 256ra136, 2014. View at Publisher · View at Google Scholar
  49. A. Fornoni, J. Sageshima, C. Wei et al., “Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis,” Science Translational Medicine, vol. 3, no. 85, Article ID 85ra46, 2011. View at Publisher · View at Google Scholar · View at Scopus